1. Algorithm for guideline-directed medical therapy for patients with SIHD. Colors correspond to the class of recommendations in the ACCF/AHATable The algorithms do not represent a comprehensive list of recommendations (see text for all recommendations). aThe use of bile acid sequestrant is relatively contraindicated when triglycerides are 200 mg/dL and is contraindicated when triglycerides are 500 mg/dL. bDietary supplement niacin must not be used as a substitute for prescription niacin. (ACCF, American College of Cardiology Foundation; ACEI, angiotensin-converting enzyme inhibitor; AHA, American Heart Association; ARB, angiotensin receptor blocker; ASA, aspirin; ATP III, Adult Treatment Panel 3; BP, blood pressure; CCB, calcium channel blocker; CKD, chronic kidney disease; HDL-C, high-density lipoprotein cholesterol; JNC VII, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; LDL-C, low-density lipoprotein cholesterol; LV, left ventricular; MI, myocardial infarction; NHLBI, National Heart, Lung, and Blood Institute; NTG, nitroglycerin.)
Source: Chapter 6. Ischemic Heart Disease, Pharmacotherapy: A Pathophysiologic Approach, 9e
Citation: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. Pharmacotherapy: A Pathophysiologic Approach, 9e; 2014 Available at: Accessed: March 04, 2018
Copyright © 2018 McGraw-Hill Education. All rights reserved